GlassScriptPhysician profile
Robert N Piana
NPI 1629068556
$16,348.85
in general payments reported to CMS, 2019-2025
8 companies · $4,189 in 2025
The $4,189 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,195 · 2020: $4,800 · 2021: $56.78 · 2022: $1,629 · 2023: $750 · 2024: $1,728 · 2025: $4,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,900 · Food and Beverage: $2,035 · Travel and Lodging: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,900.00 |
| Food and Beverage | $2,034.93 |
| Travel and Lodging | $732.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,762.38 | 2019-2025 | Cardiomems, Pressurewire |
| Edwards Lifesciences Corporation | $2,985.64 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Abiomed | $564.88 | 2023-2024 | Impella |
| Teleflex LLC | $424.86 | 2022-2025 | Guideliner, Trapliner |
| Boston Scientific Corporation | $281.25 | 2023-2025 | Avvigo Guidance System |
| Medtronic, INC. | $169.19 | 2021-2025 | Ffrangio |
| Siemens Medical Solutions USA, INC. | $160.65 | 2023 | Biograph Horizon-3r |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Piana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.